China Financial Statements From 2010 to 2024
| CHME Stock | USD 0.0002 0.00 0.00% |
Check China Medicine financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among China Medicine's main balance sheet or income statement drivers, such as , as well as many indicators such as . China financial statements analysis is a perfect complement when working with China Medicine Valuation or Volatility modules.
China |
China Medicine Company Operating Margin Analysis
China Medicine's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current China Medicine Operating Margin | 0.18 % |
Most of China Medicine's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, China Medicine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, China Medicine has an Operating Margin of 0.178%. This is 100.51% lower than that of the Pharmaceuticals sector and 97.52% lower than that of the Health Care industry. The operating margin for all United States stocks is 103.23% lower than that of the firm.
China Medicine Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining China Medicine's current stock value. Our valuation model uses many indicators to compare China Medicine value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across China Medicine competition to find correlations between indicators driving China Medicine's intrinsic value. More Info.China Medicine is rated third in return on equity category among its peers. It is number one stock in return on asset category among its peers reporting about 1.18 of Return On Asset per Return On Equity. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the China Medicine's earnings, one of the primary drivers of an investment's value.About China Medicine Financial Statements
China Medicine stakeholders use historical fundamental indicators, such as China Medicine's revenue or net income, to determine how well the company is positioned to perform in the future. Although China Medicine investors may analyze each financial statement separately, they are all interrelated. For example, changes in China Medicine's assets and liabilities are reflected in the revenues and expenses on China Medicine's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in China Medicine. Please read more on our technical analysis and fundamental analysis pages.
China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China. CHINA MEDICINE operates under Medical Distribution classification in the United States and is traded on OTC Exchange. It employs 281 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in China Pink Sheet
China Medicine financial ratios help investors to determine whether China Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Medicine security.